A phase I trial of ISIS 426115 (ISIS GCCRRx) in volunteers

Trial Profile

A phase I trial of ISIS 426115 (ISIS GCCRRx) in volunteers

Phase of Trial: Phase I

Latest Information Update: 18 Jun 2013

At a glance

  • Drugs IONIS GCCRrx (Primary) ; Dexamethasone
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Jun 2013 Results presented at the 95th Annual Meeting of the Endocrine Society.
    • 07 Dec 2012 Positive results were reported in an Isis Pharmaceuticals media release.
    • 07 Dec 2012 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top